Lirametostat ( CPI-1205 ) is a potent, selective, and cofactor-competitive inhibitor of wild type and mutant EZH2 catalytic activity, which demonstrates anti-proliferative effects in prostate and other cancer cell models.
For research use only. We do not sell to patients.
| Name | Lirametostat ( CPI-1205 ) |
|---|---|
| Iupac Chemical Name | (R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide |
| Synonyms | CPI-1205 ; CPI 1205 ; CPI1205 ; Lirametostat |
| Molecular Formula | C27H33F3N4O3 |
| Molecular Weight | 518.57 |
| Smile | O=C(C1=C(C)N([C@@H](C2CCN(CC(F)(F)F)CC2)C)C3=C1C=CC=C3)NCC4=C(OC)C=C(C)NC4=O |
| InChiKey | HPODOLXTMDHLLC-QGZVFWFLSA-N |
| InChi | InChI=1S/C27H33F3N4O3/c1-16-13-23(37-4)21(25(35)32-16)14-31-26(36)24-18(3)34(22-8-6-5-7-20(22)24)17(2)19-9-11-33(12-10-19)15-27(28,29)30/h5-8,13,17,19H,9-12,14-15H2,1-4H3,(H,31,36)(H,32,35)/t17-/m1/s1 |
| CAS Number | 1621862-70-1 |
| Related CAS | 1621862-70-1 |
| Packaging | Price | Availability | Purity | Shipping Time |
|---|---|---|---|---|
| Bulk | Enquiry | Enquiry | Enquiry |
| Formulation | Off-white solid to white solid |
|---|---|
| Purity | ≧98.0% |
| Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
| Solubility | Soluble in DMSO |
| Handling | Avoid inhalation, contact with eyes and skin. Avoid dust and aerosol formation. Use only in areas with appropriate exhaust ventilation. |
| Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. |
| HS Code | 2934200090 |
| Targets | |
|---|---|
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study |